Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Metabolon's Quantose(TM) Prediabetes Tests Now Available in Europe Through Collaboration With Metdia Biotech
September 17, 2014 11:05 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., Sept. 17, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it has partnered with Metdia Biotech, S.L. to commercialize its...
Metabolon to Sponsor Study at Geisinger Medical Center With Quantose IR to Monitor Prediabetes Therapy
June 23, 2014 16:16 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 23, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announced today that it will sponsor a pilot study to evaluate its Quantose IRTM test...
New Data on Metabolon's Prediabetes Test to be Featured in Two Poster Presentations at ADA Conference
June 12, 2014 12:22 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 12, 2014 (GLOBE NEWSWIRE) -- Metabolon, Inc., a global leader in metabolomics, announces that two posters highlighting data from studies using its Quantose IGTTM...
Metabolon Announces Quantose IR Test Launched in Mexico to Help Prevent Type 2 Diabetes
June 04, 2014 15:34 ET
|
Metabolon, Inc.
RESEARCH TRIANGLE PARK, N.C., June 4, 2014 (GLOBE NEWSWIRE) -- Metabolon, a global leader in metabolomics, announced today that its Quantose IR™ prediabetes test is now available to physicians...